<--- Back to Details
First PageDocument Content
Non-small-cell lung carcinoma / Immunotherapy / Cancer / PD-1 / Targeted therapy / Metastasis / Carcinogenesis / Bevacizumab / Galena Biopharma / Medicine / Lung cancer / Cancer treatments
Date: 2015-02-03 02:46:54
Non-small-cell lung carcinoma
Immunotherapy
Cancer
PD-1
Targeted therapy
Metastasis
Carcinogenesis
Bevacizumab
Galena Biopharma
Medicine
Lung cancer
Cancer treatments

Microsoft Word - 150202_PDL-1_final_en

Add to Reading List

Source URL: www.roche.com

Download Document from Source Website

File Size: 105,12 KB

Share Document on Facebook

Similar Documents

Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

DocID: 1vjEy - View Document

RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

DocID: 1vfqs - View Document

Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth.

DocID: 1v3MR - View Document

Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital

DocID: 1v06s - View Document

Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath

DocID: 1uZ8r - View Document